By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Adaptive Biotechnologies 

307 Westlake Avenue N
Suite 300
Seattle  Washington  98109  U.S.A.
Phone: 206-659-0067 Fax: 206-659-0667


SEARCH JOBS


Industry
Biotechnology






Company News
Adaptive Biotechnologies CEO To Present And Join Distinguished Panel At 33rd Annual J.P. Morgan Healthcare Conference 1/12/2015 9:57:15 AM
Adaptive Biotechnologies Banks $94 Million, Buys Bay Area's Sequenta, Inc. 1/8/2015 6:42:42 AM
Adaptive Biotechnologies Announces Acquisition Of Sequenta, Inc. 1/7/2015 11:02:12 AM
Adaptive Biotechnologies And Collaborators Present 13 Studies Demonstrating Clinical Relevance Of Immunosequencing At 56th Annual Meeting Of The American Society of Hematology 12/2/2014 10:25:53 AM
Adaptive Biotechnologies Release: Study Published In Nature Suggests immunoSEQ™ Assay May Be Used To Predict Response To Anti-PD-1 Therapy For Melanoma 11/26/2014 11:58:30 AM
Adaptive Biotechnologies Launches The immunoSEQ Kit To Enable Researchers To Sequence The Adaptive Immune System In Their Own Labs 11/25/2014 8:57:53 AM
Adaptive Biotechnologies Announces The Formation Of A Hematologic Malignancies Scientific Advisory Board 9/29/2014 10:17:19 AM
Veteran Genoptix, Inc. And Gen-Probe Incorporated (Acquired by Hologic) (GPRO) Executive, Brian Hansen, Joins Adaptive Biotechnologies As Chief Commercial Officer 9/17/2014 7:48:23 AM
Veteran Microsoft Executive And Distinguished Engineer, Sean Nolan, Joins Adaptive Biotechnologies As Chief Technology Officer 7/8/2014 10:24:52 AM
Adaptive Biotechnologies Release: Study Reports clonoSEQ™ Detects Residual Disease In 33% More Childhood Leukemia Patients Compared To Current Standard Of Care Laboratory Test 6/27/2014 9:40:43 AM
123
//-->